ロード中...
Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis
Tofacitinib is a Janus kinase 1–3 inhibitor initially approved for the treatment of rheumatoid arthritis and now approved for the treatment of moderately to severely active ulcerative colitis (UC). We present the case of a patient with UC and seronegative inflammatory arthritis in whom arthritis pro...
保存先:
| 出版年: | ACG Case Rep J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6831149/ https://ncbi.nlm.nih.gov/pubmed/31750389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/crj.0000000000000226 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|